• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌中多效生长因子浓度升高。

Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer.

作者信息

Jee Youn Hee, Sadowski Samira M, Celi Francesco S, Xi Liqiang, Raffeld Mark, Sacks David B, Remaley Alan T, Wellstein Anton, Kebebew Electron, Baron Jeffrey

机构信息

Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.

Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

出版信息

PLoS One. 2016 Feb 25;11(2):e0149383. doi: 10.1371/journal.pone.0149383. eCollection 2016.

DOI:10.1371/journal.pone.0149383
PMID:26914549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4767803/
Abstract

BACKGROUND

Thyroid nodules are common, and approximately 5% of these nodules are malignant. Pleiotrophin (PTN) is a heparin-binding growth factor which is overexpressed in many cancers. The expression of PTN in papillary thyroid cancer (PTC) is unknown.

METHOD AND FINDINGS

74 subjects (age 47 ± 12 y, 15 males) who had thyroidectomy with a histological diagnosis: 79 benign nodules and 23 PTCs (10 classic, 6 tall cell, 6 follicular variant and 1 undetermined). Fine-needle aspiration (FNA) samples were obtained ex vivo from surgically excised tissue and assayed for PTN and thyroglobulin (Tg). Immunohistochemistry (IHC) was performed on tissue sections. In FNA samples, PTN concentration normalized to Tg was significantly higher in PTC than in benign nodules (16 ± 6 vs 0.3 ± 0.1 ng/mg, p < 0.001). In follicular variant of PTC (n = 6), the PTN/Tg ratio was also higher than in benign nodules (1.3 ± 0.6 vs 0.3 ± 0.1 ng/mg, P < 0.001, respectively). IHC showed cytoplasmic localization of PTN in PTC cells.

CONCLUSION

In ex vivo FNA samples, the PTN to thyroglobulin ratio was higher in PTCs, including follicular variant PTC, than in benign thyroid nodules. The findings raise the possibility that measurement of the PTN to Tg ratio may provide useful diagnostic and/or prognostic information in the evaluation of thyroid nodules.

摘要

背景

甲状腺结节很常见,其中约5%为恶性。多效生长因子(PTN)是一种肝素结合生长因子,在许多癌症中过度表达。PTN在甲状腺乳头状癌(PTC)中的表达尚不清楚。

方法与结果

74例接受甲状腺切除术的受试者(年龄47±12岁,男性15例),组织学诊断为:79个良性结节和23个PTC(10个经典型、6个高细胞型、6个滤泡变体型和1个未定型)。细针穿刺(FNA)样本取自手术切除的组织并进行体外检测,以测定PTN和甲状腺球蛋白(Tg)。对组织切片进行免疫组织化学(IHC)检测。在FNA样本中,PTC中PTN浓度相对于Tg的标准化值显著高于良性结节(16±6 vs 0.3±0.1 ng/mg,p<0.001)。在PTC的滤泡变体型(n=6)中,PTN/Tg比值也高于良性结节(分别为1.3±0.6 vs 0.3±0.1 ng/mg,P<0.001)。IHC显示PTN在PTC细胞中呈细胞质定位。

结论

在体外FNA样本中,包括滤泡变体型PTC在内的PTC中PTN与甲状腺球蛋白的比值高于良性甲状腺结节。这些发现增加了一种可能性,即测量PTN与Tg的比值可能为甲状腺结节的评估提供有用的诊断和/或预后信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b09/4767803/e194ce6b2d3f/pone.0149383.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b09/4767803/08e3d3da910f/pone.0149383.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b09/4767803/c2fa83b8c022/pone.0149383.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b09/4767803/e194ce6b2d3f/pone.0149383.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b09/4767803/08e3d3da910f/pone.0149383.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b09/4767803/c2fa83b8c022/pone.0149383.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b09/4767803/e194ce6b2d3f/pone.0149383.g003.jpg

相似文献

1
Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer.甲状腺乳头状癌中多效生长因子浓度升高。
PLoS One. 2016 Feb 25;11(2):e0149383. doi: 10.1371/journal.pone.0149383. eCollection 2016.
2
Midkine concentrations in fine-needle aspiration of benign and malignant thyroid nodules.良性和恶性甲状腺结节细针穿刺中的中期因子浓度。
Clin Endocrinol (Oxf). 2015 Dec;83(6):977-84. doi: 10.1111/cen.12676. Epub 2015 Jan 15.
3
Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.利用甲状腺乳头状癌残留的常规细针穿刺标本检测BRAF基因c.1799T > A(p.V600E)突变
Diagn Cytopathol. 2015 Oct;43(10):786-90. doi: 10.1002/dc.23302. Epub 2015 Jul 7.
4
Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results.甲状腺球蛋白在甲状腺乳头状癌淋巴结细针抽吸洗脱液中的应用:确定良恶性的界值的大规模验证及结果差异评估。
J Clin Endocrinol Metab. 2013 Mar;98(3):1061-8. doi: 10.1210/jc.2012-3291. Epub 2013 Feb 7.
5
Measurement of fine-needle aspiration thyroglobulin levels increases the detection of metastatic papillary thyroid carcinoma in cystic neck lesions.细针穿刺甲状腺球蛋白水平的检测可提高囊性颈部病变中转移性乳头状甲状腺癌的检出率。
Cancer Cytopathol. 2014 Jul;122(7):521-6. doi: 10.1002/cncy.21413. Epub 2014 Mar 3.
6
Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".BRAF突变检测在细针穿刺活检样本中诊断为“疑似甲状腺乳头状癌”时的应用价值
Head Neck. 2015 Dec;37(12):1788-93. doi: 10.1002/hed.23829. Epub 2014 Sep 25.
7
Immunohistochemistry for BRAF(V600E) antibody VE1 performed in core needle biopsy samples identifies mutated papillary thyroid cancers.在粗针活检样本中进行的BRAF(V600E)抗体VE1免疫组化可识别出突变型甲状腺乳头状癌。
Horm Metab Res. 2014 May;46(5):370-4. doi: 10.1055/s-0034-1368700. Epub 2014 Feb 25.
8
Use of BRAF v600e immunocytochemistry on FNA direct smears of papillary thyroid carcinoma.BRAF v600e免疫细胞化学在甲状腺乳头状癌细针穿刺直接涂片上的应用。
Cancer Cytopathol. 2015 Sep;123(9):531-9. doi: 10.1002/cncy.21575. Epub 2015 Jun 16.
9
Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.突变特异性BRAF和CD117免疫细胞化学可能有助于在细针穿刺活检标本中对甲状腺乳头状癌进行风险分层。
Tumour Biol. 2016 Jan;37(1):611-8. doi: 10.1007/s13277-015-3837-9. Epub 2015 Aug 4.
10
Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.免疫组织化学在甲状腺乳头状癌细针穿刺活检中检测 BRAF(V600E) 突变的价值。
Cancer Cytopathol. 2014 Jan;122(1):48-58. doi: 10.1002/cncy.21352. Epub 2013 Sep 4.

引用本文的文献

1
Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.两个世界的碰撞:天然化合物与非编码转录本在癌症治疗中的相互作用
Front Pharmacol. 2021 Jul 6;12:652074. doi: 10.3389/fphar.2021.652074. eCollection 2021.
2
Association of Midkine and Pleiotrophin Gene Polymorphisms With Systemic Lupus Erythematosus Susceptibility in Chinese Han Population.中微子和多效生长因子基因多态性与汉族人群系统性红斑狼疮易感性的关联。
Front Immunol. 2020 Feb 21;11:110. doi: 10.3389/fimmu.2020.00110. eCollection 2020.
3
Lowered levels of microRNA-129 and potential signaling pathways in papillary thyroid carcinoma: a determination of microRNA sequencing in 507 patients and bioinformatics analysis.

本文引用的文献

1
PTN signaling: Components and mechanistic insights in human ovarian cancer.PTN信号传导:人类卵巢癌中的组成部分及机制见解
Mol Carcinog. 2015 Dec;54(12):1772-85. doi: 10.1002/mc.22249. Epub 2014 Nov 21.
2
Midkine concentrations in fine-needle aspiration of benign and malignant thyroid nodules.良性和恶性甲状腺结节细针穿刺中的中期因子浓度。
Clin Endocrinol (Oxf). 2015 Dec;83(6):977-84. doi: 10.1111/cen.12676. Epub 2015 Jan 15.
3
Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.
甲状腺乳头状癌中微小RNA-129水平降低及潜在信号通路:507例患者的微小RNA测序测定及生物信息学分析
Int J Clin Exp Pathol. 2017 Jul 1;10(7):7511-7527. eCollection 2017.
4
Tumor-associated macrophages increase the proportion of cancer stem cells in lymphoma by secreting pleiotrophin.肿瘤相关巨噬细胞通过分泌多效生长因子增加淋巴瘤中癌症干细胞的比例。
Am J Transl Res. 2019 Oct 15;11(10):6393-6402. eCollection 2019.
5
Luteolin suppresses colorectal cancer cell metastasis via regulation of the miR‑384/pleiotrophin axis.木犀草素通过调节 miR-384/pleiotrophin 轴抑制结直肠癌细胞转移。
Oncol Rep. 2019 Jul;42(1):131-141. doi: 10.3892/or.2019.7136. Epub 2019 Apr 24.
6
LncRNA CRNDE promotes cell proliferation, invasion and migration by competitively binding miR-384 in papillary thyroid cancer.长链非编码RNA CRNDE通过竞争性结合微小RNA-384促进甲状腺乳头状癌的细胞增殖、侵袭和迁移。
Oncotarget. 2017 Nov 30;8(66):110552-110565. doi: 10.18632/oncotarget.22819. eCollection 2017 Dec 15.
7
Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein.多效生长因子通过上调P-糖蛋白促进骨肉瘤对阿霉素的化疗耐药性。
Oncotarget. 2017 Jul 10;8(38):63857-63870. doi: 10.18632/oncotarget.19148. eCollection 2017 Sep 8.
8
Midkine and pleiotrophin concentrations in needle biopsies of breast and lung masses.乳腺和肺肿块针吸活检中中期因子和多效蛋白浓度。
Cancer Biomark. 2017 Sep 7;20(3):299-307. doi: 10.3233/CBM-170145.
BRAF(V600E)突变检测与RAS点突变及RET/PTC重排评估在甲状腺癌诊断中的相关性
Thyroid. 2015 Feb;25(2):221-8. doi: 10.1089/thy.2014.0338. Epub 2014 Nov 24.
4
Follicular lesions of the thyroid.甲状腺滤泡性病变
Surg Clin North Am. 2014 Jun;94(3):499-513. doi: 10.1016/j.suc.2014.02.005. Epub 2014 Apr 3.
5
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.胶质母细胞瘤干细胞的致瘤性需要多效生长因子-间变性淋巴瘤激酶轴。
Oncogene. 2014 Apr 24;33(17):2236-44. doi: 10.1038/onc.2013.168. Epub 2013 May 20.
6
Expression and localization of receptor protein tyrosine phosphatase β and its ligand pleiotrophin in the submandibular gland of mice.受体蛋白酪氨酸磷酸酶β及其配体多效生长因子在小鼠颌下腺中的表达与定位
Arch Oral Biol. 2013 Feb;58(2):181-91. doi: 10.1016/j.archoralbio.2012.09.005. Epub 2012 Oct 23.
7
Implications of pleiotrophin in human PC3 prostate cancer cell growth in vivo.在体人前列腺癌细胞 PC3 生长中多效蛋白的意义。
Cancer Sci. 2012 Oct;103(10):1826-32. doi: 10.1111/j.1349-7006.2012.02383.x. Epub 2012 Aug 14.
8
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.术前诊断不确定细胞学的良性甲状腺结节。
N Engl J Med. 2012 Aug 23;367(8):705-15. doi: 10.1056/NEJMoa1203208. Epub 2012 Jun 25.
9
Midkine in the pathology of cancer, neural disease, and inflammation.中期因子在癌症、神经疾病和炎症中的作用。
Pathol Int. 2012 Jul;62(7):445-55. doi: 10.1111/j.1440-1827.2012.02815.x. Epub 2012 Mar 27.
10
Pleiotrophin expression during odontogenesis.牙发生过程中的多效蛋白表达。
J Histochem Cytochem. 2012 May;60(5):366-75. doi: 10.1369/0022155412439316. Epub 2012 Feb 29.